We are live on
!
Find out more
JE
JMAC Enterprises Portfolio holdings
AUM
$522M
1-Year Est. Return
15.34%
This Fund
S&P 500
This Quarter
Est. Return
-3.82%
1 Year Est. Return
+15.34%
3 Year Est. Return
+52.85%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$425M
AUM Growth
+$229K
(+0.05%)
Cap. Flow
-$1.19M
Cap. Flow
% of AUM
-0.28%
Top 10 Holdings %
Top 10 Hldgs %
39.92%
Holding
180
New
9
Increased
69
Reduced
53
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
IFLN
Invesco Bloomberg Enhanced Fallen Angels ETF
IFLN
|
+$1.11M |
| 2 |
Microsoft
MSFT
|
+$682K |
| 3 |
Vanguard Real Estate ETF
VNQ
|
+$623K |
| 4 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$555K |
| 5 |
First Trust NASDAQ Cybersecurity ETF
CIBR
|
+$518K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$1.45M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$459K |
| 3 |
Vanguard Consumer Discretionary ETF
VCR
|
+$446K |
| 4 |
PACCAR
PCAR
|
+$432K |
| 5 |
Global X US Infrastructure Development ETF
PAVE
|
+$421K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 8.86% |
| 2 | Technology | 5.15% |
| 3 | Consumer Staples | 2.71% |
| 4 | Consumer Discretionary | 2.25% |
| 5 | Financials | 2.2% |
Similar funds
LT
SC
TCM
GS
WFA
SCM
SW
ETS
JMAC Enterprises's Q1 2022 Portfolio in Review
As of Q1 2022, JMAC Enterprises held 180 positions worth $425M, up 0.05% from $425M the previous quarter. Its ten largest holdings account for 40% of the portfolio.
JMAC Enterprises's Q1 2022 filing shows 9 new, 69 increased, 53 reduced and 5 closed positions. Its largest new stake was Invesco Bloomberg Enhanced Fallen Angels ETF: 59,150 shares worth $1.09M. The largest sale was Amgen, an estimated $1.45M.
By sector, the portfolio is most concentrated in Healthcare at 8.9% of assets, down from 9.3% a quarter earlier, followed by Technology and Consumer Staples.
- JMAC Enterprises's largest Q1 2022 buy was Invesco Bloomberg Enhanced Fallen Angels ETF: 59,150 shares worth $1.09M.
- JMAC Enterprises added most to Microsoft in Q1 2022, an estimated $682K increase.
- JMAC Enterprises's biggest Q1 2022 reduction was Amgen, cutting an estimated $1.45M.
- JMAC Enterprises fully exited PACCAR in Q1 2022, selling an estimated $432K.
- JMAC Enterprises's ten largest holdings make up 40% of its $425M portfolio in Q1 2022.
- JMAC Enterprises opened 9 new positions and closed 5 in Q1 2022.
- JMAC Enterprises's portfolio value rose 0.05% quarter-over-quarter to $425M.
Based on JMAC Enterprises's 13F filing for Q1 2022, filed 16 May 2022.